Light
Dark
System
Log In
Loading...
Compare / EASA/
Incorporated Amendments
/
Compare & Highlight Differences
AMC17 MED.C.025 Content of aero-medical assessments
Available versions for ERULES-1963177438-11210
ED Decision 2019/002/R
found in: Aircrew (1178/2011) Part-FCL Part-MED Part-CC Part-ARA Part-ORA Part-DTO (Aug 2023)
From
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
From section
To
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
To section
No visible text changes
0 removals
0 additions
View
Rich
Plain
Sync scrolling
Share
From
Show details
Hide details
To
Show details
Hide details
Version
Show side by side
AMC17 MED.C.025 Content of aero-medical assessments ED Decision 2019/002/R ONCOLOGY (a) After treatment for malignant disease, cabin crew members should undergo satisfactory oncological and aero-medical evaluation before a fit assessment may be considered. (b) Cabin crew members with an established history or clinical diagnosis of intracerebral malignant tumour should be assessed as unfit. Considering the histology of the tumour, a fit assessment may be considered after successful treatment and recovery.
AMC17 MED.C.025 Content of aero-medical assessments ED Decision 2019/002/R ONCOLOGY (a) After treatment for malignant disease, cabin crew members should undergo satisfactory oncological and aero-medical evaluation before a fit assessment may be considered. (b) Cabin crew members with an established history or clinical diagnosis of intracerebral malignant tumour should be assessed as unfit. Considering the histology of the tumour, a fit assessment may be considered after successful treatment and recovery.
##### AMC17 MED.C.025 Content of aero-medical assessments *ED Decision 2019/002/R* **ONCOLOGY** (a) After treatment for malignant disease, cabin crew members should undergo satisfactory oncological and aero-medical evaluation before a fit assessment may be considered. (b) Cabin crew members with an established history or clinical diagnosis of intracerebral malignant tumour should be assessed as unfit. Considering the histology of the tumour, a fit assessment may be considered after successful treatment and recovery.